Grant: Collaborative Research and Development Grants
École Polytechnique de Montréal
$71,799.00
Real-time intraoperative spectroscopic tumor margin detection in robotic-assisted radical prostatectomy on prostate cancer patients
FY 2016-17
Summary
Surgical removal of the tumor is the front-line therapy and successful patient outcomes rely on removing the most cancer cells possible. ODS Medical's has developed an intra-operative system that uses a hand-held probe to pinpoint cancerous tissue for removal past the margins identified by conventional technologies. Using an optical effect, known as Raman spectroscopy to recognize the molecular signature of cancers, it can distinguish between normal and cancerous tissue, all in a fraction of a second. While original demonstrations were done in the brain, these technologies are by no means limited to brain cancer. We accumulated evidence to support the extension of ODS Medical's cancer detecting probe to Radical Prostatectomy, an important standard of care for patients suffering from prostate cancer. This multi-disciplinary project proposes the engineering development and intraoperative in vivo evaluation of a molecular imaging (Raman spectroscopy and intrinsic tissue fluorescence) robotic platform with the goal of improving cancer detection accuracy during robotic assisted radical prostatectomy procedures on prostate cancer patients. Academic applicants have partnered with ODS Medical, Intuitive Surgical, MEDTEQ, CR-CHUM and the Princess Margaret Cancer Center for this project. Upon success, the project will improve the accuracy and completeness of tumor resections which can have a direct impact on patient survival and quality-of-life as well as lead to a reduction in healthcare costs by reducing inefficiencies and costs of standard surgical procedures. Since 4 out of 5 radical prostatectomies are performed using the Intuitive robotic system, there is a significant potential market for integrating optical imaging technologies which can create important revenue for Canadian startup ODS Medical. The project will also contribute to putting Canada at the forefront of high-tech research.
Program
Collaborative Research and Development Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
500162-2016
Name nom
Lesage, Frederic
Department département
Génie Biomédical, Institut de
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
71799
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
2
Application title
Real-time intraoperative spectroscopic tumor margin detection in robotic-assisted radical prostatectomy on prostate cancer patients
Keyword
NSERC
Application summary
Surgical removal of the tumor is the front-line therapy and successful patient outcomes rely on removing the most cancer cells possible. ODS Medical's has developed an intra-operative system that uses a hand-held probe to pinpoint cancerous tissue for removal past the margins identified by conventional technologies. Using an optical effect, known as Raman spectroscopy to recognize the molecular signature of cancers, it can distinguish between normal and cancerous tissue, all in a fraction of a second. While original demonstrations were done in the brain, these technologies are by no means limited to brain cancer. We accumulated evidence to support the extension of ODS Medical's cancer detecting probe to Radical Prostatectomy, an important standard of care for patients suffering from prostate cancer. This multi-disciplinary project proposes the engineering development and intraoperative in vivo evaluation of a molecular imaging (Raman spectroscopy and intrinsic tissue fluorescence) robotic platform with the goal of improving cancer detection accuracy during robotic assisted radical prostatectomy procedures on prostate cancer patients. Academic applicants have partnered with ODS Medical, Intuitive Surgical, MEDTEQ, CR-CHUM and the Princess Margaret Cancer Center for this project. Upon success, the project will improve the accuracy and completeness of tumor resections which can have a direct impact on patient survival and quality-of-life as well as lead to a reduction in healthcare costs by reducing inefficiencies and costs of standard surgical procedures. Since 4 out of 5 radical prostatectomies are performed using the Intuitive robotic system, there is a significant potential market for integrating optical imaging technologies which can create important revenue for Canadian startup ODS Medical. The project will also contribute to putting Canada at the forefront of high-tech research.